The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lyophilisation in Pharmaceutical Market Research Report 2025
Synopsis
It refers to the drying method of freezing the drug solution at low temperature, and then sublimating and drying under vacuum conditions, removing ice crystals, and then desorbing and drying after the sublimation is completed, and removing part of the bound water.
Global Lyophilisation in Pharmaceutical market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lyophilisation in Pharmaceutical market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Lyophilisation in Pharmaceutical market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bristol-Myers Squibb
Gilead Sciences
Novo Nordisk
Sanofi
Aurobindo Pharma
Fresenius Kabi
Merck
Zydus Group
Vetter Pharma
Roche
JNJ
Takeda Pharma
Cipla
Segment by Type
Anticancer Drugs
Antiarrhythmic Drugs
Anti-Infectives
Other
Segment by Application
Hospital
Clinic
Other
Production by Region
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Lyophilisation in Pharmaceutical report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
It refers to the drying method of freezing the drug solution at low temperature, and then sublimating and drying under vacuum conditions, removing ice crystals, and then desorbing and drying after the sublimation is completed, and removing part of the bound water.
Global Lyophilisation in Pharmaceutical market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lyophilisation in Pharmaceutical market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Lyophilisation in Pharmaceutical market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bristol-Myers Squibb
Gilead Sciences
Novo Nordisk
Sanofi
Aurobindo Pharma
Fresenius Kabi
Merck
Zydus Group
Vetter Pharma
Roche
JNJ
Takeda Pharma
Cipla
Segment by Type
Anticancer Drugs
Antiarrhythmic Drugs
Anti-Infectives
Other
Segment by Application
Hospital
Clinic
Other
Production by Region
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Lyophilisation in Pharmaceutical report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Index1 Lyophilisation in Pharmaceutical Market Overview
1.1 Product Definition
1.2 Lyophilisation in Pharmaceutical Segment by Type
1.2.1 Global Lyophilisation in Pharmaceutical Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Anticancer Drugs
1.2.3 Antiarrhythmic Drugs
1.2.4 Anti-Infectives
1.2.5 Other
1.3 Lyophilisation in Pharmaceutical Segment by Application
1.3.1 Global Lyophilisation in Pharmaceutical Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Market Growth Prospects
1.4.1 Global Lyophilisation in Pharmaceutical Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Lyophilisation in Pharmaceutical Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Lyophilisation in Pharmaceutical Production Estimates and Forecasts (2018-2029)
1.4.4 Global Lyophilisation in Pharmaceutical Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Lyophilisation in Pharmaceutical Production Market Share by Manufacturers (2018-2023)
2.2 Global Lyophilisation in Pharmaceutical Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Lyophilisation in Pharmaceutical, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Lyophilisation in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Lyophilisation in Pharmaceutical Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Lyophilisation in Pharmaceutical, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Lyophilisation in Pharmaceutical, Product Offered and Application
2.8 Global Key Manufacturers of Lyophilisation in Pharmaceutical, Date of Enter into This Industry
2.9 Lyophilisation in Pharmaceutical Market Competitive Situation and Trends
2.9.1 Lyophilisation in Pharmaceutical Market Concentration Rate
2.9.2 Global 5 and 10 Largest Lyophilisation in Pharmaceutical Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Lyophilisation in Pharmaceutical Production by Region
3.1 Global Lyophilisation in Pharmaceutical Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Lyophilisation in Pharmaceutical Production Value by Region (2018-2029)
3.2.1 Global Lyophilisation in Pharmaceutical Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Lyophilisation in Pharmaceutical by Region (2024-2029)
3.3 Global Lyophilisation in Pharmaceutical Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Lyophilisation in Pharmaceutical Production by Region (2018-2029)
3.4.1 Global Lyophilisation in Pharmaceutical Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Lyophilisation in Pharmaceutical by Region (2024-2029)
3.5 Global Lyophilisation in Pharmaceutical Market Price Analysis by Region (2018-2023)
3.6 Global Lyophilisation in Pharmaceutical Production and Value, Year-over-Year Growth
3.6.1 North America Lyophilisation in Pharmaceutical Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Lyophilisation in Pharmaceutical Production Value Estimates and Forecasts (2018-2029)
3.6.3 Asia-Pacific Lyophilisation in Pharmaceutical Production Value Estimates and Forecasts (2018-2029)
3.6.4 Latin America Lyophilisation in Pharmaceutical Production Value Estimates and Forecasts (2018-2029)
3.6.5 Middle East & Africa Lyophilisation in Pharmaceutical Production Value Estimates and Forecasts (2018-2029)
4 Lyophilisation in Pharmaceutical Consumption by Region
4.1 Global Lyophilisation in Pharmaceutical Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Lyophilisation in Pharmaceutical Consumption by Region (2018-2029)
4.2.1 Global Lyophilisation in Pharmaceutical Consumption by Region (2018-2023)
4.2.2 Global Lyophilisation in Pharmaceutical Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Lyophilisation in Pharmaceutical Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Lyophilisation in Pharmaceutical Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Lyophilisation in Pharmaceutical Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Lyophilisation in Pharmaceutical Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Lyophilisation in Pharmaceutical Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Lyophilisation in Pharmaceutical Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Lyophilisation in Pharmaceutical Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Lyophilisation in Pharmaceutical Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Lyophilisation in Pharmaceutical Production by Type (2018-2029)
5.1.1 Global Lyophilisation in Pharmaceutical Production by Type (2018-2023)
5.1.2 Global Lyophilisation in Pharmaceutical Production by Type (2024-2029)
5.1.3 Global Lyophilisation in Pharmaceutical Production Market Share by Type (2018-2029)
5.2 Global Lyophilisation in Pharmaceutical Production Value by Type (2018-2029)
5.2.1 Global Lyophilisation in Pharmaceutical Production Value by Type (2018-2023)
5.2.2 Global Lyophilisation in Pharmaceutical Production Value by Type (2024-2029)
5.2.3 Global Lyophilisation in Pharmaceutical Production Value Market Share by Type (2018-2029)
5.3 Global Lyophilisation in Pharmaceutical Price by Type (2018-2029)
6 Segment by Application
6.1 Global Lyophilisation in Pharmaceutical Production by Application (2018-2029)
6.1.1 Global Lyophilisation in Pharmaceutical Production by Application (2018-2023)
6.1.2 Global Lyophilisation in Pharmaceutical Production by Application (2024-2029)
6.1.3 Global Lyophilisation in Pharmaceutical Production Market Share by Application (2018-2029)
6.2 Global Lyophilisation in Pharmaceutical Production Value by Application (2018-2029)
6.2.1 Global Lyophilisation in Pharmaceutical Production Value by Application (2018-2023)
6.2.2 Global Lyophilisation in Pharmaceutical Production Value by Application (2024-2029)
6.2.3 Global Lyophilisation in Pharmaceutical Production Value Market Share by Application (2018-2029)
6.3 Global Lyophilisation in Pharmaceutical Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Lyophilisation in Pharmaceutical Corporation Information
7.1.2 Bristol-Myers Squibb Lyophilisation in Pharmaceutical Product Portfolio
7.1.3 Bristol-Myers Squibb Lyophilisation in Pharmaceutical Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Bristol-Myers Squibb Main Business and Markets Served
7.1.5 Bristol-Myers Squibb Recent Developments/Updates
7.2 Gilead Sciences
7.2.1 Gilead Sciences Lyophilisation in Pharmaceutical Corporation Information
7.2.2 Gilead Sciences Lyophilisation in Pharmaceutical Product Portfolio
7.2.3 Gilead Sciences Lyophilisation in Pharmaceutical Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Gilead Sciences Main Business and Markets Served
7.2.5 Gilead Sciences Recent Developments/Updates
7.3 Novo Nordisk
7.3.1 Novo Nordisk Lyophilisation in Pharmaceutical Corporation Information
7.3.2 Novo Nordisk Lyophilisation in Pharmaceutical Product Portfolio
7.3.3 Novo Nordisk Lyophilisation in Pharmaceutical Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Novo Nordisk Main Business and Markets Served
7.3.5 Novo Nordisk Recent Developments/Updates
7.4 Sanofi
7.4.1 Sanofi Lyophilisation in Pharmaceutical Corporation Information
7.4.2 Sanofi Lyophilisation in Pharmaceutical Product Portfolio
7.4.3 Sanofi Lyophilisation in Pharmaceutical Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Sanofi Main Business and Markets Served
7.4.5 Sanofi Recent Developments/Updates
7.5 Aurobindo Pharma
7.5.1 Aurobindo Pharma Lyophilisation in Pharmaceutical Corporation Information
7.5.2 Aurobindo Pharma Lyophilisation in Pharmaceutical Product Portfolio
7.5.3 Aurobindo Pharma Lyophilisation in Pharmaceutical Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Aurobindo Pharma Main Business and Markets Served
7.5.5 Aurobindo Pharma Recent Developments/Updates
7.6 Fresenius Kabi
7.6.1 Fresenius Kabi Lyophilisation in Pharmaceutical Corporation Information
7.6.2 Fresenius Kabi Lyophilisation in Pharmaceutical Product Portfolio
7.6.3 Fresenius Kabi Lyophilisation in Pharmaceutical Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Fresenius Kabi Main Business and Markets Served
7.6.5 Fresenius Kabi Recent Developments/Updates
7.7 Merck
7.7.1 Merck Lyophilisation in Pharmaceutical Corporation Information
7.7.2 Merck Lyophilisation in Pharmaceutical Product Portfolio
7.7.3 Merck Lyophilisation in Pharmaceutical Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Merck Main Business and Markets Served
7.7.5 Merck Recent Developments/Updates
7.8 Zydus Group
7.8.1 Zydus Group Lyophilisation in Pharmaceutical Corporation Information
7.8.2 Zydus Group Lyophilisation in Pharmaceutical Product Portfolio
7.8.3 Zydus Group Lyophilisation in Pharmaceutical Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Zydus Group Main Business and Markets Served
7.7.5 Zydus Group Recent Developments/Updates
7.9 Vetter Pharma
7.9.1 Vetter Pharma Lyophilisation in Pharmaceutical Corporation Information
7.9.2 Vetter Pharma Lyophilisation in Pharmaceutical Product Portfolio
7.9.3 Vetter Pharma Lyophilisation in Pharmaceutical Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Vetter Pharma Main Business and Markets Served
7.9.5 Vetter Pharma Recent Developments/Updates
7.10 Roche
7.10.1 Roche Lyophilisation in Pharmaceutical Corporation Information
7.10.2 Roche Lyophilisation in Pharmaceutical Product Portfolio
7.10.3 Roche Lyophilisation in Pharmaceutical Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Roche Main Business and Markets Served
7.10.5 Roche Recent Developments/Updates
7.11 JNJ
7.11.1 JNJ Lyophilisation in Pharmaceutical Corporation Information
7.11.2 JNJ Lyophilisation in Pharmaceutical Product Portfolio
7.11.3 JNJ Lyophilisation in Pharmaceutical Production, Value, Price and Gross Margin (2018-2023)
7.11.4 JNJ Main Business and Markets Served
7.11.5 JNJ Recent Developments/Updates
7.12 Takeda Pharma
7.12.1 Takeda Pharma Lyophilisation in Pharmaceutical Corporation Information
7.12.2 Takeda Pharma Lyophilisation in Pharmaceutical Product Portfolio
7.12.3 Takeda Pharma Lyophilisation in Pharmaceutical Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Takeda Pharma Main Business and Markets Served
7.12.5 Takeda Pharma Recent Developments/Updates
7.13 Cipla
7.13.1 Cipla Lyophilisation in Pharmaceutical Corporation Information
7.13.2 Cipla Lyophilisation in Pharmaceutical Product Portfolio
7.13.3 Cipla Lyophilisation in Pharmaceutical Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Cipla Main Business and Markets Served
7.13.5 Cipla Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Lyophilisation in Pharmaceutical Industry Chain Analysis
8.2 Lyophilisation in Pharmaceutical Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Lyophilisation in Pharmaceutical Production Mode & Process
8.4 Lyophilisation in Pharmaceutical Sales and Marketing
8.4.1 Lyophilisation in Pharmaceutical Sales Channels
8.4.2 Lyophilisation in Pharmaceutical Distributors
8.5 Lyophilisation in Pharmaceutical Customers
9 Lyophilisation in Pharmaceutical Market Dynamics
9.1 Lyophilisation in Pharmaceutical Industry Trends
9.2 Lyophilisation in Pharmaceutical Market Drivers
9.3 Lyophilisation in Pharmaceutical Market Challenges
9.4 Lyophilisation in Pharmaceutical Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
